In the study versus insulin glargine, insulin detemir was allowed to be administered once or twice daily whereas insulin glargine was to be administered once a day, 55% of the insulin detemir-treated subjects completed the 52 weeks of treatment on the twice daily regimen.
55% af de personer, som blev behandlet med insulin detemir, fuldførte de 52 uger s behandling med et behandlingsregime på to gange daglig.